Recent insider trading activity from Langsam Jeffrey, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Oncology Institute, Inc. | $TOI | Langsam Jeffrey | Chief Clinical Officer | A | Common Stock | 70270 | $0.00 | 127,650.0000 | 99,303,511 | 122.46% | 0.07% |
| May 21, 2025 | Oncology Institute, Inc. | $TOI | Langsam Jeffrey | Chief Clinical Officer | A | Common Stock | 57380 | $0.00 | 57,380.0000 | 90,661,800 | 9999.99% | 0.06% |